Vivo Ventures Fund V, L.p. - Net Worth and Insider Trading
Vivo Ventures Fund V, L.p. Net Worth
The estimated net worth of Vivo Ventures Fund V, L.p. is at least $79 Million dollars as of 2024-11-08. Vivo Ventures Fund V, L.p. is the 10% Owner of Sagent Pharmaceuticals Inc and owns about 3,013,764 shares of Sagent Pharmaceuticals Inc (SGNT) stock worth over $66 Million. Vivo Ventures Fund V, L.p. is also the 10% Owner of Soleno Therapeutics Inc and owns about 242,254 shares of Soleno Therapeutics Inc (SLNO) stock worth over $14 Million. Details can be seen in Vivo Ventures Fund V, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vivo Ventures Fund V, L.p. has not made any transactions after 2019-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vivo Ventures Fund V, L.p.
Vivo Ventures Fund V, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vivo Ventures Fund V, L.p. owns 3 companies in total, including Soleno Therapeutics Inc (SLNO) , Sagent Pharmaceuticals Inc (SGNT) , and MEI Pharma Inc (MEIP) .
Click here to see the complete history of Vivo Ventures Fund V, L.p.’s form 4 insider trades.
Insider Ownership Summary of Vivo Ventures Fund V, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 2019-12-02 | 10 percent owner |
| SGNT | Sagent Pharmaceuticals Inc | 2016-08-29 | 10 percent owner |
| MEIP | MEI Pharma Inc | 2012-12-18 | 10 percent owner |
Vivo Ventures Fund V, L.p. Latest Holdings Summary
Vivo Ventures Fund V, L.p. currently owns a total of 2 stocks. Among these stocks, Vivo Ventures Fund V, L.p. owns 3,013,764 shares of Sagent Pharmaceuticals Inc (SGNT) as of April 21, 2016, with a value of $66 Million and a weighting of 82.58%. Vivo Ventures Fund V, L.p. also owns 242,254 shares of Soleno Therapeutics Inc (SLNO) as of December 2, 2019, with a value of $14 Million and a weighting of 17.42%.
Latest Holdings of Vivo Ventures Fund V, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGNT | Sagent Pharmaceuticals Inc | 2016-04-21 | 3,013,764 | 21.76 | 65,579,505 |
| SLNO | Soleno Therapeutics Inc | 2019-12-02 | 242,254 | 57.11 | 13,835,126 |
Holding Weightings of Vivo Ventures Fund V, L.p.
Vivo Ventures Fund V, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Vivo Ventures Fund V, L.p. has made a total of 0 transactions in Sagent Pharmaceuticals Inc (SGNT) over the past 5 years. The most-recent trade in Sagent Pharmaceuticals Inc is the sale of 2,005 shares on April 21, 2016, which brought Vivo Ventures Fund V, L.p. around $27,168.
According to the SEC Form 4 filings, Vivo Ventures Fund V, L.p. has made a total of 5 transactions in Soleno Therapeutics Inc (SLNO) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Soleno Therapeutics Inc is the sale of 2,269 shares on December 2, 2019, which brought Vivo Ventures Fund V, L.p. around $55,125.
Insider Trading History of Vivo Ventures Fund V, L.p.
- 1
Vivo Ventures Fund V, L.p. Trading Performance
Vivo Ventures Fund V, L.p. Ownership Network
Ownership Network List of Vivo Ventures Fund V, L.p.
Ownership Network Relation of Vivo Ventures Fund V, L.p.
Vivo Ventures Fund V, L.p. Owned Company Details
What does Soleno Therapeutics Inc do?
Who are the key executives at Soleno Therapeutics Inc?
Vivo Ventures Fund V, L.p. is the 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include See Remarks Patricia C Hirano , See Remarks Kristen Yen , and director & See Remarks Bhatnagar Anish .
Soleno Therapeutics Inc (SLNO) Insider Trades Summary
Over the past 18 months, Vivo Ventures Fund V, L.p. made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 479,373 shares made by Bhatnagar Anish , a net sale of 79,014 shares made by Kristen Yen , and a net sale of 47,490 shares made by Patricia C Hirano .
In summary, during the past 3 months, insiders sold 1,210,871 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 1,210,871 shares. During the past 18 months, 2,825,824 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net sale of 1,615,737 shares.
Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Soleno Therapeutics Inc Insider Transactions
Vivo Ventures Fund V, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Vivo Ventures Fund V, L.p.. You might contact Vivo Ventures Fund V, L.p. via mailing address: 505 Hamilton Avenue, Suite 200, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
